Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutritional Oncology Research Institute (NORI) is a private U.S.-based oncology nutrition and nutraceutical organization that offers home-based nutritional support programs for cancer patients and survivors. The group positions itself as an independent research organization developing nutritionally based therapies and nutraceutical products intended to support cancer treatment and long-term disease management. Its core commercial offerings center on the NORI Protocol and Targeted Amino Acid Deprivation Therapy (TAADT), which emphasize dietary amino acid restriction, nutritional counseling, and related supplement products. NORI also operates NORI Nutraceuticals, a product division that manufactures and sells supplements used within its programs. The organization appears to function more as a direct-to-patient nutritional oncology and nutraceutical business than as a conventional drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutritional Oncology Research Institute.